Among solid tumors, endometrial carcinoma has the highest rate of alterations in the PI3K/AKT/mTOR pathway, with specific alterations in this pathway observed in 92% of type I and 60% of type II endometrial carcinomas (75). The gene discussed is AKT1; the disease is endometrial carcinoma.